Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are still factors like manufacturing maze, investment, logistics and regulatory challenges which prevents the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our 4th Annual MarketsandMarkets Next Gen Bioprocessing Conference.
We will launching this physical meet in Boston, USA that will be beneficial for speakers, attendees and sponsors/exhibitors, taking place on 23rd - 24th June 2022.
Learn from the leading experts of the industry about strategies, technologies and innovations in the area of bioprocessing of cell-gene therapies.
CEO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Investigators, Heads, Managers, Principal scientists, Scientists, Professors, Lecturers, Group Heads, Researchers from Pharmaceuticals/Therapeutics/Cell-Gene therapy-based companies working on :
• Bioprocess development • GMP/Manufacturing
• Cellular Therapy • Gene Therapy
• Cell Engineering • Cell culture operations
• mRNA type therapeutics • ATMP (Advanced therapy medicinal products)